Related Experiment Video
Updated: Feb 4, 2026

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy
Published on: January 24, 2017
EXD2: A new regulator of mitochondrial translation and potential target for cancer therapy
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Abstract:
In recent work we identified Exonuclease 3'-5' domain-containing protein 2 (EXD2) as an RNase required for efficient mitochondrial translation. Here I describe in brief the cellular phenotypes caused by EXD2 deficiency and make the case that EXD2 inhibitors could be valuable agents for cancer therapy.
Insights
Exonuclease 3'-5' domain-containing protein 2 (EXD2) is crucial for mitochondrial translation. EXD2 deficiency causes cellular defects, suggesting EXD2 inhibitors may be effective cancer therapies.
Area of Science:
- Mitochondrial biology
- Molecular genetics
- Cancer research
Background:
- Exonuclease 3 -5 domain-containing protein 2 (EXD2) has been identified as an essential RNase.
- EXD2 plays a critical role in maintaining efficient mitochondrial translation.
Purpose of the Study:
- To briefly describe the cellular phenotypes associated with EXD2 deficiency.
- To propose EXD2 inhibitors as potential cancer therapeutics.
Main Methods:
- Analysis of cellular phenotypes resulting from EXD2 deficiency.
- Review of existing literature on EXD2 function and cancer biology.
Main Results:
- EXD2 deficiency leads to observable cellular abnormalities.
- The study posits a link between EXD2 function and cancer progression.
Conclusions:
- EXD2 is vital for mitochondrial translation efficiency.
- Targeting EXD2 with inhibitors presents a promising avenue for cancer treatment strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Translational Regulation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Animal Mitochondrial Genetics
Export of Mitochondrial and Chloroplast Genes
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...

